South Asia's cardiometabolic burden: exposomal determinants of a health transition
Open access0 citations
Abstract
South Asia is facing an escalating burden of obesity, type 2 diabetes (T2D), dyslipidemia, metabolic dysfunction–associated steatotic liver disease (MASLD), and premature atherosclerotic cardiovascular disease.1–4 In 2023, high systolic blood pressure (SBP) accounted for nearly 138 million disability-adjusted life years (DALYs) and 6.27 million deaths across the Asia–Pacific region, while high body mass index, elevated LDL cholesterol, and T2D collectively contributed to more than 150 million DALYs.
// Source
View paper (DOI)Open access versionOpenAlexThe Lancet Regional Health - Southeast AsiaPublished 2026-10-07
Authors: Yashendra Sethi, Anoop Misra
Institutions: Swami Vivekanand Subharti University, Subharti Medical College, National Diabetes Obesity and Cholesterol Foundation, Diabetes Foundation